care.ai Launches Collaboration with Google Cloud, Bringing Transformative Ambient Monitoring Solution to More Health Systems

Google Cloud Marketplace Now Offers Smart Care Facility Platform, Enhancing Hospital's Ability to Provide Optimal Care

care.ai, the pioneering AI-driven Smart Care Facility Platform in healthcare, today revealed a continuous collaboration with Google Cloud, making care.ai’s range of groundbreaking care solutions available on Google Cloud Marketplace. Healthcare organizations and care facilities can now access the company’s Virtual Nursing solution via Google Cloud Marketplace, ultimately making it easier for organizations to adopt care.ai’s Smart Care Facility Platform.

care.ai’s technology revolutionizes care environments, such as hospitals and nursing homes, by creating responsive facilities that optimize clinical and operational workflows, addressing some of the most pressing healthcare challenges today. As traditional care models become financially unsustainable and the nursing shortage calls for over 1 million new registered nurses by 2030, the healthcare system faces increasing pressure. care.ai’s platform harnesses advanced sensors and artificial intelligence to establish the foundational infrastructure for unmatched awareness within the smart facility, automating labor-intensive processes, saving nurses’ time, and minimizing the need for multiple technology systems by integrating ambient and virtual care workflows within a single platform.

“Our Smart Care Facility Platform, with generative AI, is ushering in new multimodal experiences that enhance and improve how clinicians work and interact with patients,” said Chakri Toleti, care.ai CEO and founder. “Collaborating with Google Cloud allows us to introduce our Platform to a broader array of hospitals and nursing homes worldwide, streamlining clinical care operations and elevating care quality by enabling clinicians to focus on delivering more empathetic and timely care. We anticipate further collaboration opportunities with Google Cloud and are excited to continue revolutionizing healthcare together.”

care.ai’s Smart Care Facility Platform is now accessible on Google’s Cloud Marketplace. This partnership between care.ai and Google Cloud will enable acute and post-acute facilities to engage with the company’s platform seamlessly and securely.

“Ambient intelligence holds the potential to resolve numerous issues plaguing healthcare facilities today, from workforce shortages to disjointed patient care,” said Riju Khetarpal, director of Healthcare and Life Sciences ISV Partnerships at Google Cloud. “Care.ai’s ambient monitoring solution, now available on the Google Cloud Marketplace, gives healthcare organizations the ability to easily integrate care.ai’s technology with their existing systems.”

Sourcecare.ai

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.